Scientists at Stanford are developing a painless, topical vaccine using a common skin bacterium to trigger immunity.

The wound is the dark hole in the middle of the image (1). The immune cells are blue (2), and a kind of common skin bacterium called Staphylococcus epidermidis is shown in green (3). The white and red ...

Staphylococcus epidermidis exhibits different patterns of colonization to skin epithelial layers, which may contribute to long-term colonization. The microbial surface components recognizing ...

Instead of injections, they are investigating whether a common skin bacterium, Staphylococcus epidermidis, could deliver vaccines through a simple topical cream. The discovery challenges long-held ...

But a few hardy microbes call it home. Among them is Staphylococcus epidermidis, a generally harmless skin-colonizing bacterial species. “These bugs reside on every hair follicle of virtually every ...

epidermidis and S ... Central venous catheter-related blood stream infection (CRBSI)—most often with Staphylococcus aureus or S. epidermis—is a common complication and cause of death among ...

A painless future of vaccination could be on the horizon, as researchers have been working on innovative delivery methods. Stanford University scientists have now presented another unique method ...